Effects of Aerobic and Resistance Exercises on Physical Symptoms in Cancer Patients: A Meta-analysis by Nakano Jiro et al.
Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-
NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction 




2018, Vol. 17(4) 1048 –1058
© The Author(s) 2018 
Article reuse guidelines:
sagepub.com/journals-permissions 




An estimated 21.6 million new cancer cases are expected 
worldwide by 2030. This estimate is a stark 53% increase 
from the latest statistics reported by the World Health 
Organization in 2012. As screening and treatment continue 
to progress, the overall number of cancer patients and survi-
vors will increase.1 Although mortality rates have reduced, 
many cancer patients still suffer from physical and psycho-
logical symptoms. Cancer patients have various physical 
symptoms. Common symptoms include fatigue, nausea/
vomiting, pain, dyspnea, insomnia (sleep disturbance), loss 
of appetite, constipation, diarrhea, drowsiness, hair loss, 
sore mouth, and sweating.2 The 3 types of symptoms are 
acute, chronic, and late symptoms. Acute symptoms develop 
before or during treatment but have a short duration. 
Chronic symptoms may continue for months or years, and 
late symptoms develop months or years after treatments are 
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Abstract
Objective. This study aimed to conduct a meta-analysis to establish the effect of exercise interventions on physical symptoms, 
including fatigue, nausea/vomiting, pain, dyspnea, insomnia, loss of appetite, constipation, and diarrhea in cancer patients 
and survivors. Methods. We searched articles published before April 2017 using the following databases: Cochrane Library, 
PubMed/MEDLINE, CINAHL, Scopus, PEDro, Health & Medical Collection, and Psychology Database. Randomized controlled 
trials (RCTs) of exercise intervention in cancer patients, which evaluated cancer-related physical symptoms using the European 
Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30, were included. Symptom scale data 
were extracted for meta-analysis. Subgroup analyses were performed for exercise types (aerobic, resistance, and mixed 
exercise programs). Results. Of the 659 articles, 10 RCTs were included in the meta-analysis, of which the mean PEDro score 
was 5.43 (SD = 1.28). Fatigue, pain, dyspnea, and insomnia were significantly lower in the intervention group than in the 
control group at postintervention in cancer patients. However, exercise intervention did not promote or suppress nausea/
vomiting, loss of appetite, constipation, and diarrhea in cancer patients. The effect of exercise type on each symptom was 
not different. Conclusion. Exercise intervention was confirmed to improve fatigue, pain, and insomnia and might have reduced 
dyspnea in cancer patients. However, the benefits of exercise on nausea/vomiting, loss of appetite, constipation, and diarrhea 
were not shown in any exercise type. Further research is warranted to examine the effects of exercise interventions on 
physical symptoms in cancer patients.
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completed. These 3 types of symptoms at any stage of the 
cancer trajectory have significant adverse effects on cancer 
patients.3 Symptoms also occur as side effects of opioids,4 
chemotherapy,5 and radiotherapy.6 All symptoms affect the 
quality of life (QOL) of cancer patients.
Exercise is widely recognized as an effective nonpharma-
cological therapy in cancer patients.7-9 A growing body of 
evidence supports the idea that increasing physical activity 
provides important benefits to promote psychological out-
comes and physical well-being in cancer patients.9-12 
Exercise has been reported to relieve cancer-related physical 
symptoms such as fatigue,8,13-15 pain,8,16 and insomnia.8,17,18 
However, the effects of exercise on other symptoms, includ-
ing nausea/vomiting, dyspnea, constipation, diarrhea, and 
loss of appetite, have not been confirmed by meta-analysis 
of randomized controlled trials (RCTs). On the other hand, 
the effects of exercise on physical symptoms might differ by 
type of exercise.19 Pain and insomnia have been reported to 
be relieved by aerobic, but not resistance exercise.10,16,18 
Fatigue is improved by both aerobic and resistance exer-
cises.13,14,19 Thus, aerobic and resistance exercises should be 
distinguished when the effects of exercise on cancer-related 
physical symptoms are examined.
This systematic review aimed to determine the effects of 
aerobic and resistance exercise interventions on physical 
symptoms by a meta-analysis of RCTs. These symptoms 
include not only fatigue, pain, and insomnia, but also nau-
sea/vomiting, dyspnea, loss of appetite, constipation, and 
diarrhea in cancer patients.
Methods
Protocol and Objective
The systematic review was performed according to the 
Preferred Reporting Items for Systematic Reviews and 
Meta-analyses (PRISMA) guidelines.20 It was also con-
ducted and reported in accordance with the PRISMA state-
ment20 (PROSPERO Register code: CRD42018091244). 
No funding support was received in this study.
Search Methods
We performed a literature search to identify articles pub-
lished before April 2017 using the following databases: 
Cochrane Library, the Centre for Reviews and 
Dissemination, PubMed/MEDLINE, CINAHL, Scopus, 
PEDro, Health & Medical Collection‎, and Psychology 
Database. The search strategy was adapted to each database 
and based on the following MeSH terms: cancer, tumor, 
randomized controlled trial, training, rehabilitation, and 
exercise. The words disorder for cancer were also used for 
the search (eg, lymphoma, hematopoietic malignancy, car-
cinosarcoma). In addition, the words outcome on physical 
symptoms were added to the search terms (European 
Organization for Research and Treatment of Cancer Quality 
of Life Questionnaire-C30 and C15-PAL [EORTC QLQ-
C30, QLQ-C15-PAL]). Cancer-related symptoms are fre-
quently examined using the EORTC QLQ-C30.21 The 
EORTC QLQ-C30 consists of 30 items, and raw patient 
responses are transformed to produce scores from 0 to 100 
on 5 functional scales, 9 symptom scales, and a scale repre-
senting global QOL. Higher functional scale scores indicate 
better health-related QOL, whereas higher symptom scale/
item scores indicate higher level of symptoms. QLQ-C30 
symptom scales include fatigue, nausea/vomiting, pain, 
dyspnea, insomnia, loss of appetite, constipation, and diar-
rhea. Similarly, QLQ-C15-PAL is a questionnaire devel-
oped to assess the QOL of palliative cancer care patients 
and has the same symptom scale as the QLQ-C30 except 
diarrhea. Attempts were made to contact authors of trial 
reports if clarification was necessary. Reference lists of 
identified eligible articles were cross-referenced and hand 
searched to identify any additional articles.
We included RCTs that evaluated the effects of exercise 
intervention by QLQ-C30 in cancer patients and survivors 
in any setting. Even if the primary outcome was not physi-
cal symptoms, studies that reported the QLQ-C30 symptom 
scale were included. Systematic reviews, editorials, cross-
sectional studies, case reports, and case series studies were 
excluded. The interventions were of sufficient intensity as 
measured in metabolic equivalent of task, thus excluding 
stretching exercises, yoga, Pilates, and education. The exer-
cise interventions for shoulder joint in breast cancer patients 
and pelvic floor muscle training in patients with gyneco-
logical cancer were also excluded. Comparisons were with 
a control group not receiving any (major) exercise interven-
tion or other interventions (eg, cognitive behavioral ther-
apy). Groups with only attention, relaxation, or education 
were considered as control groups.
Titles and subsequent abstracts of trials were retrieved 
and screened by 3 independent reviewers (KH, KU, and 
EM) to identify trials that met the inclusion criteria. A fourth 
independent reviewer (JN) resolved any discrepancies 
between the 2 reviewers. Full texts of potentially eligible tri-
als were retrieved and assessed for eligibility by 2 indepen-
dent reviewers (JN and TF). Articles deemed eligible were 
included after the full-text screening. To perform the meta-
analysis, data details were examined. Studies that did not 
show numerical data of QLQ-C30 at postintervention were 
excluded. Final inclusion of eligible RCTs was determined 
in consensus meetings in which all authors participated.
Quality Assessment
The methodological quality of the studies, including their 
risk of bias, was assessed using the PEDro Scale, which is 
based on the Delphi list.22 The PEDro scale scores the meth-
odological quality of randomized trials out of 10. A PEDro 
cutoff of 5 points is used widely.23 The score for each included 
study was determined by a trained assessor (JN). Additionally, 
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the score, which was shown in the PEDro physiotherapy evi-
dence database, was referred. Final scores were determined 
in consensus meetings in which all authors participated.
Data Extraction
Data were extracted by one of the authors (JN). When insuf-
ficient data were available in the full text, authors were con-
tacted by email for further information. The following data 
were extracted from each study by 2 investigators: first 
author’s last name, publication year, study location and dura-
tion, sample size, type of exercise, and timing of exercise. The 
following data from the QLQ-C30 physical symptom scales 
were selected for the meta-analysis: fatigue, nausea/vomiting, 
pain, dyspnea, insomnia, loss of appetite, constipation, and 
diarrhea. Means and SDs of postintervention were extracted. 
It is premised that no significant difference exists between the 
intervention and control groups at baseline (preintervention).
Data Analysis
All statistical analyses were conducted using Review Manager 
(RevMan) version 5.1.24 We calculated standard mean differ-
ences (SMDs) with 95% CIs. SMDs were significant if their 
95% CIs excluded zero. The random effect model was used as 
the pooling method to assume heterogeneity between different 
exercise types. We assessed statistical heterogeneity using the 
l2 statistic. We adopted the levels of l2 suggested by the 
Cochrane Handbook for Systematic Reviews of Interventions 
(l2 values of 0%, 25%, 50%, and 75% represented no, low, 
moderate, and high heterogeneity, respectively).25 The thresh-
old for interpreting the l2 value can be misleading. Therefore, 
we determined the importance of the observed l2 value by 
looking at the magnitude and direction of the effect as well as 
at the strength of evidence for clinical heterogeneity. Subgroup 
analyses were performed for exercise types (aerobic, resis-
tance, and mixed exercise programs).
Results
Study Selection
The database searches retrieved 743 references, which were 
reduced to 659 after excluding duplicate articles. The 659 
studies were subjected to title and abstract screening, and 
614 RCTs were excluded because of irrelevant study design, 
or issues with population or intervention. A full-text review 
was performed for 45 RCTs and, consequently, 35 RCTs 
were excluded. Although 2 articles were appropriate RCTs, 
they were not included in the meta-analysis because of dif-
ferences in data form.26,27 Thus, data extraction was per-
formed on 10 RCTs. Figure 1 shows the outcome of the 
search process and study selection.
Figure 1. Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) study flow diagram of the selection 
process.
Abbreviation: RCT, randomized controlled trial.
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The included studies were conducted in various coun-
tries: 4 in Germany,28-31 2 in the United States,32,33 and 1 
each in Denmark,34 South Korea,35 Australia,36 and 
Switzerland.37 Some of the RCTs were published in more 
than 1 article.
Study Characteristics
The detailed characteristics of the 10 RCTs are shown in 
Table 1. All interventions in the RCTs lasted for 16 
weeks,32 12 weeks,30,36,37 8 weeks,35 6 weeks,33,34 3 
weeks,29 or the duration of hospitalization for cancer 
treatment.28,31 The most prevalent cancer type was hema-
tological malignancy,28,31,33,37 followed by breast 
cancer.30,32,35 In 2 RCTs,29,34 participants with various 
cancer types were included.
The exercise carried out in the intervention group in 
RCTs included various exercise programs, which were 
mainly aerobic, resistance, stretching, and walking exer-
cise. The intervention exercises were difficult to classify 
strictly. In this study, the intervention exercises in the 
included RCTs were classified into 3 types: aerobic, resis-
tance, and mixed exercise programs. Aerobic exercise pro-
grams were performed in 4 RCTs,28-30,32 resistance exercise 
programs in 3 RCTs,30,33,35 and mixed exercise programs, 
including both aerobic and resistance exercise programs, in 
4 RCTs.31,34,36,37 In 1 RCT,30 aerobic and resistance exercise 
programs were performed in 2 different groups; the data 
from both groups were extracted and analyzed separately. 
The timings of the exercise interventions performed were 
mainly postsurgery, posttransplantation (hematological 
malignancy), and during chemotherapy. The QLQ-C30 was 
used as outcome for physical symptoms in all RCTs but not 
the QLQ-C15-PAL.
Risk of Bias
Given that all included studies were RCTs, the level of 
evidence from all studies was II according to the National 
Health and Medical Research Council Hierarchy of 
Evidence Scale.38 The assessment of risk of bias showed 
a mean PEDro score of 5.43 (SD = 1.28; Table 2). 
Individually, 4 RCTs showed a PEDro score of 4 points,28 
which were slightly lower than the cutoff for high-quality 
trials.23,33,35
Effect of Exercise on Physical Symptoms
A total 10 RCTs were included in a random-effects meta-
analysis.28-37 The efficacy of exercise on physical symptoms 
in cancer patients was then estimated in a forest plot. The 10 
RCTs included in this review consisted of 893 participants: 
434 in the exercise groups and 459 in the control group. In 
1 RCT,30 both effects of aerobic and resistance exercise 
programs were examined. Therefore, 11 intervention groups 
from 10 RCTs were included in the meta-analysis.
Fatigue. The meta-analysis of 11 intervention groups from 
10 RCTs28-37 showed that fatigue in the intervention group 
was significantly lower than that in the control group (SMD 
= −0.30, 95% CI = −0.46 to −0.13, P = .0004; Figure 2A). 
The statistical heterogeneity was moderate (l2 = 26%). Sub-
group analysis of exercise types demonstrated no signifi-
cant difference among the 3 subgroups (P = .39; l2 = 0%). 
Within only the mixed exercise program subgroup,31,34,36,37 
an improvement effect in favor of the intervention group 
was found (SMD = −0.41; 95% CI = −0.66 to −0.17; 
P = .0009; l2 = 46%).
Nausea/Vomiting. A meta-analysis of 10 intervention groups 
from 9 RCTs28-34,36,37 was performed. However, in 1 RCT,33 
the SMD was not calculated because the values of the mean 
and SD were zero. As a result, no significant difference in 
nausea/vomiting was found between the intervention and 
control groups (SMD = −0.09, 95% CI = −0.24 to 0.06, 
P = .24; Figure 2B). Subgroup analysis of exercise types 
also demonstrated no significant differences among the 3 
subgroups (P = .13; l2 = 51.6%).
Pain. The meta-analysis of 11 intervention groups from 10 
RCTs28-37 showed that pain in the intervention group was sig-
nificantly lower than that in the control group (SMD = −0.17, 
95% CI = −0.32 to −0.03, P = .02; Figure 2C). The statistical 
heterogeneity was low (l2 = 9%). A subgroup analysis of 
exercise types demonstrated no significant difference among 
the 3 subgroups (P = .18; l2 = 41.1%). Within only the mixed 
exercise program subgroup,31,34,36,37 an improvement effect in 
favor of the intervention group was found (SMD = −0.28; 
95% CI = −0.47 to −0.09; P = .005; l2 = 20%).
Dyspnea. The meta-analysis of 11 intervention groups 
from 10 RCTs28-37 showed that dyspnea in the intervention 
group was significantly lower than that in the control 
group (SMD = −0.22, 95% CI = −0.35 to −0.09, P = .001; 
Figure 2D). The statistical heterogeneity was low 
(l2 = 0%). Subgroup analysis of exercise types demon-
strated no significant differences among the 3 subgroups 
(P = .62; l2 = 0%). Within only the mixed exercise pro-
gram subgroup,31,34,36,37 an improvement effect in favor of 
the intervention group was found (SMD = −0.27; 95% CI 
= −0.49 to −0.06; P = .01; l2 = 33%).
Insomnia. The meta-analysis of 10 intervention groups 
from 9 RCTs28-34,36,37 showed that insomnia in the interven-
tion group was significantly lower than that in the control 
group (SMD = −0.28, 95% CI = −0.41 to −0.15, P < .0001; 
Figure 2E). The statistical heterogeneity was low (l2 = 0%). 
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significant differences among the 3 subgroups (P = .99; 
l2 = 0%). Within only the mixed exercise program sub-
group,31,34,36,37 an improvement effect in favor of the inter-
vention group was found (SMD = −0.28; 95% CI = −0.41 
to −0.15; P = .0005; l2 = 0%).
Loss of Appetite. The meta-analysis of 9 intervention groups 
from 8 RCTs28,30-34,36,37 also showed no significant differ-
ence in loss of appetite between the intervention and control 
groups (SMD = −0.08, 95% CI = −0.22 to 0.06, P = .29; 
Figure 2F). No significant difference was found among the 
3 subgroups (P = .50; l2 = 0%).
Constipation. Nine intervention groups from 8 RCTs28,30-34,36,37 
were included in the meta-analysis. However, the SMD was 
not calculated in 2 RCTs28,33 because the values of the mean 
and SD were zero in the constipation symptom scale. There-
fore, the analysis was performed for 7 groups from 6 
RCTs.30-32,34,36,37 No significant difference in constipation 
was found between the intervention and control groups 
(SMD = −0.02, 95% CI = −0.16 to 0.12, P = .80, l2 = 0%; 
Figure 2G). No significant difference was found among the 
3 subgroups (P = .97; l2 = 0%).
Diarrhea. In 2 RCTs,30,33 the SMD was not calculated 
because the values of the mean and SD were zero on the 
Diarrhea Symptom Scale. Seven intervention groups from 
7 RCTs were included in the meta-analysis.30-32,34,36 No 
significant difference was noted in diarrhea between the 
intervention and control groups (SMD = −0.09, 95% 
CI = −0.33 to 0.14, P = .45, l2 = 54%; Figure 2H). No 
significant difference was found among the 3 subgroups 
(P = .32, l2 = 12.7%).
Discussion
This systematic review aimed to examine the current body 
of evidence on the benefits of an exercise intervention for 
cancer-related physical symptoms. The physical symptoms 
included fatigue, nausea/vomiting, pain, dyspnea, insom-
nia, loss of appetite, constipation, and diarrhea, which were 
evaluated using the EORTC QLQ-C30. The effects of exer-
cise on cancer-related fatigue, pain, and insomnia were 
examined in some systematic reviews with meta-analy-
sis.8,39-41 However, to the best of our knowledge, this sys-
tematic review with meta-analyses is the first to focus on 
nausea/vomiting, dyspnea, loss of appetite, constipation, 
and diarrhea in cancer patients.
The benefits of exercise on fatigue,8,15 pain,8 and insom-
nia8,18 in cancer patients were previously confirmed statisti-
cally by meta-analysis. In particular, a large number of 
RCTs and systematic reviews on fatigue exist. Most studies 
showed the benefit of exercise on fatigue in cancer patients, 
and the result of our analysis show similar evidence. In con-
trast, only a few studies investigated the effect of exercise 
on pain and insomnia. Several meta-analyses showed the 
benefit of exercise on pain and insomnia8,18 but had insuf-
ficient reliable evidence. Our meta-analysis including 10 
RCTs showed the pooled effect of exercise on pain signifi-
cantly, which establishes the evidence for an effect of exer-
cise on pain and insomnia in cancer patients.
The important result is that exercise intervention leads 
to mild subjective improvements in dyspnea in cancer 
patients. Dyspnea is a subjective experience of breathing 
discomfort that consists of qualitatively distinct sensations 
that vary in intensity.42 Dyspnea is also a relatively com-
mon and highly debilitating symptom in cancer patients. It 
often leads to anxiety, depression, and exercise avoidance, 
thereby worsening deconditioning and reducing health-
related QOL.43 Additionally, cancer treatments are a major 
cause of dyspnea. Specifically, radiation and chemother-
apy can cause pneumonitis, pulmonary fibrosis, pulmo-
nary and cardiac toxicity, anemia, pulmonary emboli, and 
cachexia in a significant proportion of patients, all of 
which can initiate or worsen the direct cancer-related sen-
sations of dyspnea.44 Comorbid disease can be a signifi-
cant contributor, particularly if cardiac or pulmonary 
diseases are involved in cancer patients.45 The main treat-
ment for dyspnea in cancer patients is pharmacotherapy, 
such as opioids.46 Exercise may be an effective care for 
dyspnea in cancer patients. The effect of exercise on dys-
pnea in cancer patients was examined. Although the ben-
efit of exercise on respiratory function was shown clearly,47 
evidence on the effect of exercise on dyspnea in cancer 
patients from a meta-analysis was not indicated because of 
Table 2. Assessment of Methodological Quality and Risk of 
Bias With the PEDro Scale.
Author
Scoresa
Total0 1 2 3 4 5 6 7 8 9 10
Adamsen et al34 Yes 1 1 1 0 0 0 1 1 1 1 7
Baumann et al28 Yes 1 0 1 0 0 0 0 0 1 1 4
Dimeo et al29 Yes 1 1 1 0 0 0 1 0 1 1 6
Do et al35 Yes 1 0 1 0 0 0 1 0 1 0 4
Galvao et al36 Yes 1 1 1 1 0 0 0 1 1 1 7
Hacker et al33 Yes 1 1 0 1 0 0 0 0 0 1 4
Knols et al37 Yes 1 1 1 0 0 1 1 1 1 1 8
Ligibel et al32 Yes 1 0 1 0 0 1 1 0 1 1 5
Schmidt et al30 Yes 1 1 1 0 0 1 0 0 1 1 5
Wiskemann et al31 No 1 0 1 0 0 0 0 1 1 1 5
aThe criteria addressed the following issues: 0, eligibility criteria; 1, 
random allocation; 2, concealed allocation; 3, groups similar at baseline; 
4, participant blinding; 5, therapist blinding; 6, assessor blinding; 7, <15% 
dropouts; 8, intention-to-treat analysis; 9, between-group difference 
reported; 10, point estimate and variability reported. Each criterion was 
given equal weight (ie, 1 point) for a maximum sum score (criteria 1-10) 
of 10.
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Figure 2. Meta-analysis for the effect estimate of exercise on physical symptoms in cancer patients.
Standardized mean difference (SMD) was calculated for the Random effects model of meta-analysis. IV, inverse of variance; CI, confidence interval. 
Subgroups were indicated by color in forest plot: aerobic exercise (white), resistance exercise (gray) and  mixed exercise program (black). The pooled 
effects in each subgroups were not shown (see the main text for more details).
1056 Integrative Cancer Therapies 17(4)
insufficient RCTs.48 Our analysis showed evidence of this 
effect through a meta-analysis of 10 RCTs. Dyspnea is 
known to occur frequently in patients with lung cancer, 
such as non–small-cell lung cancer.48 However, the num-
ber of patients with lung cancer was small in this study; at 
most 46 out of 780 patients with lung cancer participated 
in RCTs, which included cancer patients with mixed can-
cer types.29,34 Therefore, the influence of cancer type was 
not strong enough. The results of dyspnea were not differ-
ent when subgroup analysis by cancer type was performed 
(data not shown). Although this study has several limita-
tions, the possibility of the effect of exercise on dyspnea in 
cancer patients was indicated.
Meta-analyses of the effects of exercise on nausea/
vomiting, loss of appetite, constipation, and diarrhea in 
cancer patients have not been performed. Generally, regu-
lar exercise and physical activity are speculated to be 
related to constipation, but only limited evidence is avail-
able.49 According to our meta-analysis, exercise of any 
type might not be effective on constipation in cancer 
patients, which might be induced by impact of tumor, 
opioid as side effect, or physical inactivity.50,51 This result 
also supports the negative opinion on the effect of exer-
cise on constipation.52 With regard to nausea/vomiting 
and loss of appetite, it could not be concluded whether 
exercise suppressed or promoted these symptoms. 
Exercise has been reported to promote nausea/vomiting53 
and could promote loss of appetite54 in healthy people. In 
contrast, exercise could also suppress these symptoms in 
noncancer patients.55,56 No information is available on the 
effect of exercise on diarrhea. Our meta-analysis showed 
that an effect of exercise on these symptoms was not 
found. It was also considered that exercise at least does 
not promote these symptoms in cancer patients.
In this study, subgroup analyses were performed for 
exercise types (aerobic, resistance, and mixed exercise pro-
grams). Although a statistically significant difference of 
effect among exercise types was not detected in all physical 
symptoms, the pooled effect was different for each sub-
group of exercise type. Improvement was observed in 
fatigue, insomnia, pain, and dyspnea only within the mixed 
exercise program subgroup. Further RCTs are required 
to examine the different effects of exercise type on each 
physical symptom.
This review has several important limitations that 
should be considered. First, the number of trials was 
small. The number of RCTs was reduced because the out-
come of physical symptom was limited to QLQ-C30 and 
C15-PAL, which was intended by the authors. In this 
review and meta-analysis, we found a new possibility of 
exercise as supportive care to common cancer-related 
physical symptoms. Detailed meta-analyses with various 
outcomes and assessment tools should be consequently 
performed, especially on dyspnea. Second, the number of 
RCTs that showed the significant effect of exercise on 
physical symptoms was small, but the result of overall 
effect (SMD) was significant. Only the RCT by Galvao 
et al36 reported a significant effect on all of fatigue, nau-
sea/vomiting, pain, and dyspnea in 28 patients. However, 
the weight in meta-analysis of the RCT was not very high 
(7.2% in fatigue; 7.3% in nausea/vomiting; 6.8% in pain; 
6.0% in dyspnea), but the risk of bias was low (PEDro 
score = 7). However, the heterogeneity (l2) in meta-anal-
ysis was low to moderate (26% in fatigue, 11% in nausea/
vomiting, 12% in pain, 0% in dyspnea).25 Additionally, 
when meta-analysis was performed without RCTs, which 
had high risk of bias (PEDro score < 5) per the sensitivity 
analysis, the result of overall effect (SMD) was not 
changed for all physical symptoms. Therefore, we believe 
that the results of meta-analyses in this study are accept-
able statistically. Third, the cancer type and treatment 
were not limited in this meta-analysis. Physical symp-
toms may differ by cancer type. When treatment differs 
by cancer type, physical symptoms as a side effect of 
treatments are changed. Fourth, RCTs included in the 
review had different time frames. Some were performed 
postsurgery, and others were performed posttransplanta-
tion, during chemotherapy, and at other time points. The 
RCTs that were performed during chemotherapy recorded 
high values of physical symptoms comparatively.30,34 
Finally, this review included only studies published in the 
English language as a result of selection; there is low pos-
sibility that selection was limited by language.
In conclusion, we confirmed that exercise interventions 
improve fatigue, pain, and insomnia in cancer patients, as 
observed in earlier studies.8,15,18 Additionally, the benefit of 
exercise on dyspnea in cancer patients was also observed, 
establishing the novelty of exercise as supportive care. 
Nausea/vomiting, loss of appetite, constipation, and diar-
rhea were not promoted or suppressed by any exercise type. 
Detailed meta-analyses with various outcomes and assess-
ment tools should be performed, and more studies of suffi-
cient quality are warranted.
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